Abstract
HO catalyzes the conversion of heme to bilirubin, free iron and CO. As the key enzyme in heme degradation, HO activity governs cellular heme concentration. Heme is ubiquitous and of vital importance in eukaryotes, functioning as the prosthetic moiety of various heme proteins including CYP, COX, thromboxane and prostacyclin synthases, NOS, catalase, peroxidase, and hemoglobin. Excess release of heme from myoglobin and hemoglobin has been shown to be highly toxic to several organs including the kidney. In view of the widespread utilization of heme and its potential toxicity,1 it is not surprising that tissues that normally process relatively large amounts of heme possess the biochemical means to efficiently and safely degrade the heme ring and regulate heme availability for essential functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wagener, F.A.D.T.G., E. Feldman, T. de-Witte, and N.G Abraham. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc.Soc.Exp. Biol. Med. 216:456–463, 1997.
Hebbel, R.P., W.T. Morgan, J.W. Eaton, and B.E. Hedlund. Accelerated autooxidation and heme loss due to instability of sickle hemoglobin. Proc.Natl.Acad.Sci. USA 85:237–241, 1988.
McCoubrey, W.K., Jr., T.J. Huang, and M.D. Maines. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur.J.Biochem. 247:725–732, 1997.
Abraham, N.G., G.S. Drummond, J.D. Lutton, and A. Kappas. The biological significance and physiological role of heme oxygenase. Cell.Physiol.Biochem. 6:129–168, 1996.
Nath, K.A., J. Balla, H.S. Jacob, G.M. Vercellotti, M. Levitt, and M.E. Rosenberg. Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J. Clin. Invest. 90:267–270, 1992.
Agarwal, A., J. Balla, J. Alam, A.J. Croatt, and K.A. Nath. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 48:1298–1307, 1995.
Nath, K.A., J. Balla, A.J. Croatt, and G.M. Vercellotti. Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. Kidney Int. 47:592–602, 1995.
Eisenstein, R.S., D. Garcia-Mayol, W. Pettingell, and H.N. Munro. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc.Natl.Acad.Sci.U.S.A. 88:688–692, 1991.
Furchgott, R.F. and D. Jothianandan. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52–61, 1991.
Johnson, R.A., M. Lavesa, B. Askari, N.G. Abraham, and A. Nasjletti. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25:166–169, 1995.
Johnson, R.A., M. Lavesa, K. DeSeyn, M.J. Scholer, and A. Nasjletti. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am.J.Physiol. 271:H1132–H1138, 1996.
Coceani, F., L. Kelsey, E. Seidlitz, G.S. Marks, B.E. McLaughlin, H.J. Vreman, D.K. Stevenson, M. Rabinovitch, and C. Ackerley. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br.J.Pharmacol. 120:599–608, 1997.
Kozma, F., R.A. Johnson, F. Zhang, C. Yu, X. Tong, and A. Nasjletti. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am.J.Physiol. 276:R1087–R1094, 1999.
Kaide, J.-I., F. Zhang, C. Yu, N.G. Abraham, and A. Nasjletti. Heme oxygenase (HO)-2-derived carbon monoxide (CO) is an inhibitory regulator of small renal artery reactivity to phenylephrine (PE). Hypertension 34:P151, 1999.
Zakhary, R., S.P. Gaine, J.L. Dinerman, M. Ruat, N.A. Flavahan, and S.H. Snyder. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc.Natl.Acad.Sci.U.S.A. 93:795–798, 1996.
Chakder, S., S. Rathi, X.L. Ma, and S. Rattan. Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. J. Pharmacol.Exp.Ther. 277:1376–1382, 1996.
Klatt, P., K. Schmidt, and B. Mayer. Brain nitric oxide synthase is a haemoprotein. Biochem.J 288 (Pt 1):15–17, 1992.
Wang, J.L., H.F. Cheng, M.Z. Zhang, J.A. McKanna, and R.C. Harris. Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am.J. Physiol. 275:F613–F622, 1998.
Capdevila, J., N. Chacos, J. Werringloer, R.A. Prough, and R.W. Estabrook. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc.Natl.Acad.Sci. U.S.A. 78:5362–5366, 1981.
McGifT, J.C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31:339–369, 1991.
Schwartzman, M., M.A. Carroll, D. Sacerdoti, N.G. Abraham, and J.C. McGifF. The renal cytochrome P450 system generates novel arachidonic acid metabolites. Adv.Exp.Med.Biol. 259:109–129, 1989.
Carroll, M.A., M.P. Garcia, J.R. Falck, and J.C. McGiff. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J.Pharmacol.Exp. Ther. 260:104–109, 1992.
Capdevila, J.H., J.R. Falck, and R.W. Estabrook. Cytochrome P450 and the arachidonate cascade. FASEB J. 6:731–736, 1992.
Schwartzman, M.L., K. Omata, F.M. Lin, R.K. Bhatt, J.R. Falck, and N.G. Abraham. Detection of 20-hydroxyeicosatetraenoic acid in rat urine. Biochem.Biophys.Res.Commun. 180:445–449, 1991.
Abraham, N.G., J.L. Chertkov, and J. Harrison. Gene transfer into hematopoietic stem cell: Role of adherent stromal cell layer. In Carella, A.G ed., ed. Acute Leukemias and Chronic Myelogenous Leukemia New Developments. Comm-Tur, Genova, 1993, 94–103.
Schwartzman, M.L., N.G. Abraham, J. Masferrer, M.W. Dunn, and J.C. McGiff. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. Biochem.Biophys.Res. Commun. 132:343–351, 1985.
Zou, A.P., J.T. Fleming, J.R. Falck, E.R. Jacobs, D. Gebremedhin, D.R. Harder, and R.J. Roman. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am.J.Physiol. 270.R228–R237, 1996.
Zou, A.P., H.A. Drummond, and R.J. Roman. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 27:631–635, 1996.
Carroll, M.A., M. Schwartzman, M. Baba, N.G. Abraham, and J.C. McGiff. Formation of biologically active cytochrome P450-arachidonate metabolites in renomedullary cells. Adv.Prost.Thromb. Leukot.Res. 17B:714–718, 1987.
Campbell, W.B., D. Gebremedhin, P.F. Pratt, and D.R. Harder. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ.Res. 78:415–423, 1996.
Zou, A.P., J.D. Imig, PR. Ortiz-de-Montellano, Z. Sui, J.R. Falck, and R.J. Roman. Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am.J.Physiol. 266:F934–F941, 1994.
Lin, F., A. Rios, J.R. Falck, Y. Belosludtsev, and M.L. Schwartzman. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am.J.Physiol. 269:F806–F816, 1995.
Fulton, D., J.C. McGiff, and J. Quilley. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br.J. Pharmacol. 107:722–725, 1992.
Laniado-Schwartzman, M. and N.G. Abraham. The renal cytochrome P-450 arachidonic acid system. Pediatr.Nephrol. 6:490–498, 1992.
Stec, D.E., M.R. Trolliet, J.E. Krieger, H.J. Jacob, and R.J. Roman. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. Hypertension 27:1329–1336, 1996.
Schwartzman, M.L., N.G. Abraham, M.A. Carroll, R.D. Levere, and J.C. McGiff. Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem.J. 238:283–290, 1986.
Sacerdoti, D., B. Escalante, N.G. Abraham, J.C. McGiff, R.D. Levere, and M.L. Schwartzman. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243:388–390, 1989.
Schwartzman, M.L., P. Martasek, A.R. Rios, R.D. Levere, K. Solangi, A.I. Goodman, and N.G. Abraham. Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int. 37:94–99, 1990.
Sessa, W.C., N.G. Abraham, B. Escalante, and M.L. Schwartzman. Manipulation of cytochrome P-450 dependent renal thromboxane synthase activity in spontaneously hypertensive rats. J.Hypertens. 7:37–42, 1989.
Martasek, P., K. Solangi, A.I. Goodman, R.D. Levere, R.J. Chernick, and N.G. Abraham. Properties of human kidney heme oxygenase: inhibition by synthetic heme analogues and metallopor- phyrins. Biochem.Biophys.Res.Commun. 157:480–487, 1988.
Lin, J.H., P. Villalon, P. Martasek, and N.G. Abraham. Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney. Eur.J. Biochem. 192:577–582, 1990.
Quilley, J., C.P. Bell-Quilley, and J.C. McGiff. Eicosanoids and hypertension. Hypertension Second Edition: 1995.
Martasek, P., M.L. Schwartzman, A.I. Goodman, K.B. Solangi, R.D. Levere, and N.G. Abraham. Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J.Am.Soc.Nephrol. 2:1078–1084, 1991.
Levere, R.D., P. Martasek, B. Escalante, M.L. Schwartzman, and N.G Abraham. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J.Clin. Invest 86:213–219, 1990.
da-Silva, J.L., M. Tiefenthaler, E. Park, B. Escalante, M.L. Schwartzman, R.D. Levere, and N.G. Abraham. Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats [published erratum appears in Am J Med Sci 1994 Aug;308(2):138]. Am.J.Med.Sci. 307:173–181, 1994.
Chernick, R.J., P. Martasek, R.D. Levere, R. Margreiter, and N.G. Abraham. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology 10:365–369, 1989.
Miller, A.D. and G.J. Rosman. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980–986, 989, 1989.
Yang, L., S. Quan, and N.G. Abraham. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am.J.Physiol. 277:L127–L133, 1999.
Iyer, S.N., D. Lu, M.J. Katovich, and M.K. Raizada. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc.Natl.Acad.Sci. U.S.A. 93:9960–9965, 1996.
Bakken, A.F., M.M. Thaler, and R. Schmid. Metabolic regulation of heme catabolism and bilirubin production. I. Hormonal control of hepatic heme oxygenase activity. J. Clin. Invest. 51:530–536, 1972.
Omata, K., N.G. Abraham, B. Escalante, and M.L. Schwartzman. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am.J.Physiol. 262:F8–16, 1992.
Imig, J.D., J.R. Falck, D. Gebremedhin, D.R. Harder, and R.J. Roman. Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450. Hypertension 22:357–364, 1993.
Yachie, A., Y. Niida, T. Wada, N. Igarashi, H. Kaneda, T. Toma, K. Ohta, Y. Kasahara, and S. Koizumi. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J.Clin. Invest. 103:129–135, 1999.
Poss, K.D. and S. Tonegawa. Reduced stress defense in heme oxygenase-1 deficient cells. Proc.Natl.Acad.Sci.U.S.A. 94:10925–10930, 1997.
Deramaudt, B.M., S. Braunstein, P. Remy, and N.G. Abraham. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J.Cell Biochem. 68:121–127, 1998.
Lee, P.J., J. Alam, G.W. Wiegand, and A.M.K. Choi. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc.Natl.Acad.Sci.U.S.A. 93:10393–10398, 1996.
Cheriathundam, E., S.Q. Doi, J.R. Knapp, M.Z. Jasser, J.J. Kopchick, and A.P. Alvares. Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes. Biochem.Pharmacol. 55:1481–1487, 1998.
Lavrovsky, Y., M.L. Schwartzman, R.D. Levere, A. Kappas, and N.G. Abraham. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc.Natl.Acad.Sci. U.S.A. 91:5987–5991, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yang, L., Quan, S., Abraham, N.G. (2002). Human Heme Oxygenase Gene Transfer Promotes Body Growth and Normalizes Blood Pressure in Spontaneously Hypertensive Rats Without Affecting Sprague-Dawley Rats. In: Abraham, N.G. (eds) Heme Oxygenase in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0741-3_43
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0741-3_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5219-8
Online ISBN: 978-1-4615-0741-3
eBook Packages: Springer Book Archive